When it comes to healthcare, the developed and developing worlds have the potential to do each other tremendous good. This potential has been under-realized in the biopharmaceutical industry, however, due to the absence of an entity positioned to identify shared opportunities, build partnerships, and lock together the pieces of an intricate puzzle.
Boston Oncology has the capacity to change those circumstances. We convert parties into partners, catalyze complex processes, and enable developing countries to sustain their own cancer care needs. We offer:
- Our here-and-now partnerships with global scientific leaders and local medical leaders in our target markets. As separate groups, these leaders have been unable to meet the growing needs of patients in the developing world. Collaborating with our facilitation, however, they can yield tremendous social and economic benefit.
- Our ability to organize and bind input components to sustain a complex system of research, development, validation, registration, and commercialization in each market – all for the ultimate benefit of the patient.
Regional and national leaders looking to ensure high-quality standards and a competitive pharmaceutical market
Local health institutions seeking to increase the cost-effectiveness of their oncology and biotechnology treatment processes and increase the reliable supply of pharmaceuticals
Local physicians looking to better serve their patients through enhanced treatment awareness, preventive care, and treatment supply
Contract research organizations (CROs), contract manufacturing organizations (CMOs) and pharmaceutical input suppliers seeking to increase their global presence
Local investors seeking to contribute to the strategic development of their communities and participate in cutting-edge industry
Building on our partnerships, we begin our business development process.